Genix Announces Change of AuditorNovember 14, 2022Vancouver, British Columbia, November 10, 2022 – Genix Pharmaceuticals Corporation…
Genix Announces Auditor ResignationNovember 14, 2022Vancouver, British Columbia, September 6, 2022 – Genix Pharmaceuticals Corporation…
Genix Receives Approval to Extend Warrants from the TSX Venture ExchangeJuly 28, 2022Vancouver, British Columbia, July 28, 2022 – Genix Pharmaceuticals Corporation (TSX-V: GENX; OTCQB: GENPF)…
Genix Proposes to Extend WarrantsJuly 20, 2022Vancouver, British Columbia, July 20, 2022 – Genix Pharmaceuticals Corporation…
Genix Pharmaceuticals Corporation Receives Natural Product Number for Rechlor from Health CanadaSeptember 8, 2021Vancouver, British Columbia, September 08, 2021 – Genix Pharmaceuticals Corporation (TSX-V: GENX; OTCQB: GENPF)…
Genix Pharmaceuticals Corp. Receives Approval for Drug Establishment LicenseJuly 15, 2021Vancouver, British Columbia, July 15th, 2021 – Genix Pharmaceuticals Corporation (TSX-V:…